University of Bristol: Study Aims to Understand Why COVID-19 Vaccines Can Lead to Very Rare Blood Clotting With Low Platelets
December 02, 2021
December 02, 2021
BRISTOL, England, Dec. 2 (TNSRes) -- The University of Bristol issued the following news release on Nov. 30, 2021:
A group of 11 institutions, led by the University of Liverpool and including the University of Bristol, is seeking to understand the very rare, but very serious, condition of blood clotting with low platelets in the general population, in COVID-19 infection, and potentially following vaccination.
The vast majority of people who experience a side effect from . . .
A group of 11 institutions, led by the University of Liverpool and including the University of Bristol, is seeking to understand the very rare, but very serious, condition of blood clotting with low platelets in the general population, in COVID-19 infection, and potentially following vaccination.
The vast majority of people who experience a side effect from . . .